GRIN2B Gene Early infantile epileptic encephalopathy type 27 Genetic Test
Welcome to DNA Labs UAE, where we offer comprehensive genetic testing services. Today, we will be discussing the GRIN2B Gene Early infantile epileptic encephalopathy type 27 Genetic Test. This test is designed to analyze the GRIN2B gene and identify any mutations or variants that may be causing early infantile epileptic encephalopathy type 27 (EIEE27), a rare genetic disorder characterized by seizures and developmental delay.
Test Details
The GRIN2B Gene Early infantile epileptic encephalopathy type 27 Genetic Test is a neurology-focused test offered by our Genetics department. It utilizes NGS (Next Generation Sequencing) technology to analyze the DNA sequence of the GRIN2B gene. This advanced sequencing technology allows for a comprehensive analysis of the gene, detecting even small mutations or variants that may be missed by other testing methods.
Test Components and Price
- Test Name: GRIN2B Gene Early infantile epileptic encephalopathy type 27 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
Pre Test Information
Prior to undergoing the GRIN2B Gene Early infantile epileptic encephalopathy type 27 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by GRIN2B Gene Early infantile epileptic encephalopathy type 27. This information will aid in the accurate interpretation of the test results.
Benefits of NGS Genetic Testing
NGS genetic testing for the GRIN2B gene offers several advantages. It provides valuable information for diagnosis, prognosis, and treatment options for individuals with EIEE27. By analyzing the DNA sequence of the GRIN2B gene, NGS technology can detect even small mutations or variants that may be missed by other testing methods. This comprehensive analysis allows for a more accurate diagnosis and personalized treatment plan for individuals with EIEE27.
If you suspect that you or a loved one may be affected by EIEE27, we encourage you to consult with a neurologist and consider the GRIN2B Gene Early infantile epileptic encephalopathy type 27 Genetic Test. Early detection and intervention can make a significant difference in managing this rare genetic disorder.
Test Name | GRIN2B Gene Early infantile epileptic encephalopathy type 27 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GRIN2B Gene Early infantile epileptic encephalopathy type 27 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GRIN2B Gene Early infantile epileptic encephalopathy type 27 |
Test Details | The GRIN2B gene is associated with early infantile epileptic encephalopathy type 27 (EIEE27), a rare genetic disorder characterized by seizures and developmental delay. NGS (Next Generation Sequencing) genetic testing can be used to analyze the GRIN2B gene and identify any mutations or variants that may be causing EIEE27. This type of testing can provide valuable information for diagnosis, prognosis, and treatment options for individuals with this condition. NGS genetic testing involves analyzing the DNA sequence of the GRIN2B gene using advanced sequencing technology. This allows for a comprehensive analysis of the gene and can detect even small mutations or variants that may be missed by other testing methods. Overall, NGS genetic testing for the GRIN2B gene can help provide a more accurate diagnosis and personalized treatment plan for individuals with EIEE27. |